Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

BTAI Stock Annual Income Statement. Download in Excel

BioXcel Therapeutics Inc. logo

BioXcel Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

0.57
 
USD
  
-0.02
  
(-2.96%)
Previous close: 0.588  Open: 0.571  Bid: 0.45  Ask: 0.4899
52 week range    
0.50   
   4.17
Mkt Cap: 26 M  Avg Vol (90 Days): 487,092
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 22nd November 2024

Stock Rankings

39
MarketXLS Rank
60
Value
30
Technical
28
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

BTAI Income Statement

Annual
Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-3.79-4.05-5.92-6.15
Basic EPS total-3.79-4.05-5.92-6.15
Basic weighted shares outstanding15 M16 M22 M26 M28 M29 M
Cost of sales20000.01 M
Depreciation-17000.0-155000.0188000.0297000.0327000.0318000.0
DepreciationAndAmortization-17000.0-155000.0188000.0297000.0327000.0318000.0
Diluted EPS total-1.32-2.02-3.79-4.05-5.92-6.15
Diluted normalized net income/share-4.05-5.92-6.15
Diluted weighted shares outstanding15 M16 M26 M28 M29 M
GeneralAndAdministrativeExpense5 M8 M24 M54 M69 M83 M
Gross operating profit355000.0120000.0
Income before tax-19 M-33 M-82 M-107 M-166 M-179 M
Income restructuring and M&A4 M
Interest income692000.0633000.0155000.044000.03 M6 M
InterestExpenseNonOperating20000.027000.040000.08 M13 M
InterestIncomeOperating653000.0155000.0
MiscOtherSpecialCharges-427000.0394000.0
Net income from total operations-19 M-33 M-82 M-107 M-166 M-179 M
NetIncomeCommonStockholders-19 M-33 M-82 M-107 M-166 M-179 M
NetIncomeContinuousOperations-19 M-33 M-82 M-107 M-166 M-179 M
NetNonOperatingInterestIncomeExpense692000.0-20000.0128000.04000.0-6 M-8 M
Normalized income-135 M
Operating income-20 M-34 M-82 M-107 M-160 M-172 M
Operating income before depreciation (EBITDA)-19 M-33 M-82 M-107 M-157 M-165 M
OperatingExpense-20 M-34 M82 M107 M160 M168 M
Other income net427000.0-394000.0
Other special charges807000.02 M
OtherGandA5 M8 M24 M54 M69 M83 M
OtherOperatingExpenses-155000.0345000.0365000.0410000.0392000.0
RentAndLandingFees5 M8 M
Research & development expense15 M26 M58 M53 M91 M84 M
ResearchExpense15 M26 M58 M53 M91 M84 M
RestructringAndMnAIncome4 M
Revenue per share860000.01 M
SalariesAndWages-3 M-3 M
Selling Gen & administrative expense5 M8 M24 M54 M69 M83 M
Special income/charges-807000.0-4 M
Total Income available for interest expense (EBIT)-19 M-33 M-82 M-107 M-158 M-166 M
Total common shares outstanding16 M20 M25 M28 M29 M31 M
Total net income-19 M-33 M-82 M-107 M-166 M-179 M
Total ordinary shares41 M41 M41 M41 M41 M41 M
Total revenues375000.01 M
TotalExpenses-20 M-34 M82 M107 M160 M169 M
TotalRevenue375000.01 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University